As of April 16, 2025, Spyre Therapeutics (SYRE) has a market cap of $0.77 billion USD. According to our data, Spyre Therapeutics is ranked No.5409 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.77 B |
-45.44%
|
Dec 31, 2024 | $1.40 B |
8.18%
|
Dec 29, 2023 | $1.30 B |
91.29%
|
Dec 30, 2022 | $0.68 B |
-90.53%
|
Dec 31, 2021 | $7.16 B |
-39.64%
|
Dec 31, 2020 | $11.86 B |
3.01%
|
Dec 31, 2019 | $11.52 B |
2.00%
|
Dec 31, 2018 | $11.29 B |
38.45%
|
Dec 29, 2017 | $8.16 B |
24.37%
|
Dec 30, 2016 | $6.56 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Illumina
ILMN
|
$11.80 B |
-0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Exelixis
EXEL
|
$10.23 B |
0.000 M
|
![]() USA
|
![]() Arcus Biosciences
RCUS
|
$0.85 B |
-0.000 M
|
![]() USA
|
![]() Sage Therapeutics
SAGE
|
$0.46 B |
0.000 M
|
![]() USA
|
![]() Argenx
ARGX
|
$36.92 B |
0.002 M
|
![]() Netherlands
|
![]() Catalent
CTLT
|
$11.52 B |
0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.76 B |
-0.000 M
|
![]() Canada
|
![]() Iovance Biotherapeutics
IOVA
|
$1.06 B |
-0.000 M
|
![]() USA
|
Market Cap | = | SYRE Stock Price | * | SYRE Shares Outstanding |
= | $12.71 | * | 60.26 M | |
= | $0.77 B |